Alector to participate at the cowen 42nd annual health care conference

South san francisco, calif., march 01, 2022 (globe newswire) -- alector, inc. (nasdaq: alec), a clinical-stage biotechnology company pioneering the discovery and development of immuno-neurology therapeutics, today announced management will participate in a panel discussion at the cowen annual health care conference on tuesday, march 8, 2022, at 2:10 p.m. et.

ALEC Ratings Summary

ALEC Quant Ranking